Thermo Fisher Scientific Inc. TMO recently announced the receipt of the FDA premarket approval (PMA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify epidermal growth ...
GRAIL, Inc. GRAL announced the submission of the final module of its premarket approval application to the FDA for the Galleri multi-cancer early detection (MCED) test. The FDA had previously granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results